Analysis of Resistance to Clarithromycin and Virulence Markers in Helicobacter pylori Clinical Isolates from Eastern Taiwan

Tzu Chi Medical Journal - Tập 21 - Trang 123-128 - 2009
Chi-Tan Hu1,2, Pei-Yu Chiou3, Chao-Chuan Wu4, Yi-Hsiung Tseng5, Yao-Jen Chang4, Nien-Tsung Lin6
1Department of Gastroenterology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
2Department of Internal Medicine, Tzu Chi University, Hualien, Taiwan
3Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan
4Department of Surgery, Buddhist Tzu Chi General Hospital, Taipei branch, Taipei, Taiwan
5Institute of Medical Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan
6Institute of Microbiology, Immunology and Molecular Medicine, Tzu Chi University, Hualien, Taiwan

Tài liệu tham khảo

Dunn, 1997, Helicobacter pylori, Clin Microbiol Rev, 10, 720, 10.1128/CMR.10.4.720 Taylor, 1995, Epidemiology and natural history of H. pylori infections, 551 Graham, 1992, Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study, Ann Intern Med, 116, 705, 10.7326/0003-4819-116-9-705 Parsonnet, 1994, Helicobacter pylori infection and gastric lymphoma, N Engl J Med, 330, 1267, 10.1056/NEJM199405053301803 Forman, 1994, H pylori and gastric cancer, Lancet, 343, 243, 10.1016/S0140-6736(94)91034-0 Parsonnet, 1994, Gastric adenocarcinoma and Helicobacter pylori infection, West J Med, 161, 60 Sipponen, 1991, Helicobacter pylori and chronic gastritis: an increased risk of peptic ulcer? A review, Scand J Gastroenterol Suppl, 186, 6, 10.3109/00365529109103980 Hu, 2007, Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan, J Gastroenterol Hepatol, 22, 720 Versalovic, 1996, Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori, Antimicrob Agents Chemother, 40, 477, 10.1128/AAC.40.2.477 Taylor, 1997, Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations, Antimicrob Agents Chemother, 41, 2621, 10.1128/AAC.41.12.2621 Occhialini, 1997, Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes, Antimicrob Agents Chemother, 41, 2724, 10.1128/AAC.41.12.2724 Stone, 1996, Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori, Helicobacter, 1, 227, 10.1111/j.1523-5378.1996.tb00043.x Hulten, 1997, Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients, Antimicrob Agents Chemother, 41, 2550, 10.1128/AAC.41.11.2550 Kim, 2002, Mutations in the 23S rRNA gene of Helicobacter pylori associated with clarithromycin resistance, J Korean Med Sci, 17, 599, 10.3346/jkms.2002.17.5.599 Toracchio, 2004, Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori, Helicobacter, 9, 396, 10.1111/j.1083-4389.2004.00267.x van Doorn, 1998, Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori, Gastroenterology, 115, 58, 10.1016/S0016-5085(98)70365-8 Wu, 2005, Clinical relevance of the vacA, iceA, cagA, and flaA genes of Helicobacter pylori strains isolated in Eastern Taiwan, J Clin Microbiol, 43, 2913, 10.1128/JCM.43.6.2913-2915.2005 Covacci, 1993, Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer, Proc Natl Acad Sci USA, 90, 5791, 10.1073/pnas.90.12.5791 Atherton, 1997, Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori, Gastroenterology, 112, 92, 10.1016/S0016-5085(97)70223-3 Elviss, 2004, Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales, J Antimicrob Chemother, 54, 435, 10.1093/jac/dkh343 Yakoob, 2004, Genetic and phenotype changes following in vitro interactions between Helicobacter pylori strains, J Gastroenterol Hepatol, 19, 626, 10.1111/j.1440-1746.2004.03352.x Stege, 2006, Analysis of resistance to clarithromycin and iceA status in Helicobacter pylori isolates from San Luis, Argentina, Int J Antimicrob Agents, 28, 477, 10.1016/j.ijantimicag.2006.08.022 Cellini, 2006, Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy, Scand J Gastroenterol, 41, 280, 10.1080/00365520510024223 Akopyanz, 1992, PCR-based RFLP analysis of DNA sequence diversity in the gastric pathogen Helicobacter pylori, Nucleic Acids Res, 20, 6221, 10.1093/nar/20.23.6221 Pena, 2001, Molecular resistance testing of Helicobacter pylori in gastric biopsies, Arch Pathol Lab Med, 125, 493, 10.5858/2001-125-0493-MRTOHP Megraud, 2004, H pylori antibiotic resistance: prevalence, importance, and advances in testing, Gut, 53, 1374, 10.1136/gut.2003.022111 Fallone, 2000, Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada, Can J Gastroenterol, 14, 879, 10.1155/2000/562159 Osato, 2001, Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States, Arch Intern Med, 161, 1217, 10.1001/archinte.161.9.1217 Mohammadi, 2003, Clarithromycin resistance in Iranian H. pylori strains before introduction of clarithromycin, Helicobacter, 8, 80, 10.1046/j.1523-5378.2003.00137_3.x Samra, 2002, Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime, J Antimicrob Chemother, 49, 1023, 10.1093/jac/dkf041 Kato, 2000, Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan, Antimicrob Agents Chemother, 44, 2214, 10.1128/AAC.44.8.2214-2216.2000 Yang, 2001, Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children, Pediatr Infect Dis J, 20, 662, 10.1097/00006454-200107000-00005 Huang, 2000, Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy, J Formos Med Assoc, 99, 704 Ling, 2002, The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997–2001), Helicobacter, 7, 327, 10.1046/j.1523-5378.2002.00101_1.x Kim, 2001, Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea, J Antimicrob Chemother, 47, 459, 10.1093/jac/47.4.459 van Doorn, 1999, Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance, Antimicrob Agents Chemother, 43, 1779, 10.1128/AAC.43.7.1779 Hao, 2004, New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China, World J Gastroenterol, 10, 1075, 10.3748/wjg.v10.i7.1075 Versalovic, 1997, Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance, J Antimicrob Chemother, 40, 283, 10.1093/jac/40.2.283 Stone, 1997, A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori, Antimicrob Agents Chemother, 41, 712, 10.1128/AAC.41.3.712 Alarcon, 2000, Clarithromycin resistance stability in Helicobacter pylori: influence of the MIC and type of mutation in the 23S rRNA, J Antimicrob Chemother, 46, 613, 10.1093/jac/46.4.613 van Doorn, 2001, Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study, Antimicrob Agents Chemother, 45, 1500, 10.1128/AAC.45.5.1500-1504.2001 Kato, 2002, Antibiotic resistance of Helicobacter pylori strains in Japanese children, J Clin Microbiol, 40, 649, 10.1128/JCM.40.2.649-653.2002 Pan, 2002, Assessment of clarithromycin-resistant Helicobacter pylori among patients in Shanghai and Guangzhou, China, by primer-mismatch PCR, J Clin Microbiol, 40, 259, 10.1128/JCM.40.1.259-261.2002 Vester, 2001, Macrolide resistance conferred by base substitutions in 23S rRNA, Antimicrob Agents Chemother, 45, 1, 10.1128/AAC.45.1.1-12.2001